Print   



Date: 6 November 2009

Dechra® Pharmaceuticals PLC

(the "Company" or the "Group")

Results of Annual General Meeting ("AGM")

Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 6 November 2009 were duly passed on a show of hands.

Copies of the following: 

• Ordinary resolution relating to the renewal of the authority for the directors to allot new shares;

• Special resolution relating to the renewal of the authority for the directors to disapply pre-emption rights;

• Special resolution relating to the renewal of the authority for the Company to purchase its own shares;

• Special resolution relating to the calling of any general meeting of the Company (other than an AGM) on not less than 14 clear days notice; and 

• Special resolution relating to the deletion of the current memorandum of Association and  adoption of new Articles of Association,

being resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM on 6 November 2009, will be submitted to the UK Listing Authority and will thereafter be available for publication at the UK Listing Authority's Document Viewing Facility which is situated at :

    Financial Services Authority

    25 The North Colonnade

    Canary Wharf

    London E14 5HS

    Tel : 020 7066 1000

  

Details of the proxy voting instructions lodged prior to the AGM are set out below:

Resolution (No. as noted on proxy form)	For	Against	Discretionary	Withheld
Resolution 1: To receive and consider report and accounts	48,564,546	29,100	108,998	120,000
Resolution 2: To receive and approve the Directors Remuneration Report	44,705,769	35,807	108,998	3,972,070
Resolution 3: To declare a final dividend	48,593,646	0	108,998	120,000
Resolution 4: To re-elect Simon Evans	47,543,459	1,049,699	108,998	120,488
Resolution 5: To re-elect Malcolm Diamond	47,152,727	1,402,148	108,998	158,771
Resolution 6: To re-appoint KPMG Audit plc as Auditors	47,912,195	6,187	783,774	120,488
Resolution 7: To authorise the Directors to fix the Auditors Remuneration	47,911,328	4,638	783,407	123,271
Resolution 8: To grant authority to allot equity securities	47,298,926	38,138	112,331	1,373,249
Resolution 9: To renew authority for pre-emptive allotment of equity securities	48,582,856	5,134	112,331	122,323
Resolution 10: To grant authority to the Company to purchase	48,583,581	6,732	112,331	120,000
Resolution 11:  To call general meetings (other than an AGM) on not less than 14 clear days notice	48,079,695	510,260	112,689	120,000
Resolution 12: To delete the existing memorandum of Association and adopt New Articles of Association	47,681,002	538,040	112,456	491,146

Enquiries:
Zoe Goulding, Company Secretary	Dechra Pharmaceuticals PLC	Tel: +44 (0) 1782 771100

Dechra and the Dechra 'D' logo are registered Trade Marks of Dechra Pharmaceuticals PLC

ENDRAGEALFKEAXNFFE